Drugs Targeting Cerebrovascular and Neurological Diseases via Green Solid Lipid Nanoparticles
DOI:
10.62233/ijrrr12
Publication Date:
2024-08-15T12:36:51Z
AUTHORS (10)
ABSTRACT
This paper explores the development of inexperienced strong lipid nanoparticles (SLNs) utilizing fatty acid coacervation as a singular method for nasal drug transport, specially focused on cerebrovascular and neurological diseases. This technique leverages the biocompatibility and biodegradability of fatty acids, offering a sustainable and powerful drug transport system.SLNs facilitate direct delivery to the brain via nasal administration, bypassing the blood-mind barrier. Characterization famous most fulfilling particle length and drug release profiles. In vitro and in vivo studies exhibit stepped forward therapeutic consequences in neurological disorders. This approach offers a promising platform for centered, powerful remedy, promoting further clinical studies and development.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....